Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Рынки
Скринер
Новости
О нас

IRMD - IRADIMED CORPORATION Последние новости | Finranks

Home

IRMD

I

IRADIMED CORPORATION (IRMD)

NGM – Цена в реальном времени. Валюта: USD

97.36

-1.38 (-1.40%)

При закрытии: Mar 27, 2026, 4:00 PM EDT

97.36

0.00 (0.00%)

После закрытия: Mar 27, 2026, 5:20 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 38 th Annual Roth Conference.

5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside

5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside

ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.

IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter

IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter

Nine Ten Capital Management sold 342,907 shares of IRadimed; the estimated transaction value was $29.42 million based on quarterly average price. The quarter-end position value decreased by $13.21 million, reflecting both share sales and price changes.

Why Iradimed Stock Soared Today

Why Iradimed Stock Soared Today

For the 18th time in a row, the niche medical device maker set a new all-time high for quarterly revenue. It also handily topped the consensus analyst estimate for adjusted net profit.

IRADIMED CORPORATION (IRMD) Q4 2025 Earnings Call Transcript

IRADIMED CORPORATION (IRMD) Q4 2025 Earnings Call Transcript

IRADIMED CORPORATION (IRMD) Q4 2025 Earnings Call Transcript

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

ORLANDO, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter and year ended December 31, 2025. The Company is a leader in developing innovative magnetic resonance imaging (“MRI”) compatible medical devices and products. The Company is a provider of (i) non-magnetic intravenous (“IV”) infusion pump systems and (ii) non-magnetic patient vital signs monitoring systems that are each designed for use during MRI procedures.

Видео

No Data

There is no data to display